Who is sponsoring NCT00636064?

NCT00636064 is sponsored by Pfizer.

What drugs are being tested in NCT00636064?

Interventions: Parecoxib Sodium/Valdecoxib, Placebo/Valdecoxib, Placebo/Placebo.

What is the status of NCT00636064?

NCT00636064 is currently COMPLETED.

Last reviewed 2008-10-09 · How we verify

A Double-Blind Multicenter Study of the Safety and Efficacy of Parecoxib Sodium/Valdecoxib and Placebo/Valdecoxib Compared to Placebo for Treatment of Post-Surgical Pain in Patients Who Have Coronary Bypass Graft Via Median Sternotomy

NCT00636064 Phase 3 COMPLETED

The purpose of this study is to evaluate the efficacy and safety of parecoxib/valdecoxib therapy and placebo/valdecoxib therapy for the treatment of pain after coronary artery bypass surgery

Details

Lead sponsor	Pfizer
Phase	Phase 3
Status	COMPLETED
Enrolment	1671
Start date	2003-01
Completion	2004-01

Conditions

Pain

Interventions

Parecoxib Sodium/Valdecoxib
Placebo/Valdecoxib
Placebo/Placebo

Primary outcomes

Combined incidence of the number of patients with at least 1 confirmed clinically relevant adverse event (CRAE) — Day 30

Countries

United States, Argentina, Australia, Austria, Belgium, Canada, Colombia, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Mexico, Netherlands, Norway, Poland, Romania, Russia, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, United Kingdom